Laurent Jerrige, JRC director for nuclear decommissioning (left), and Pavol Stuller, Amentum’s European development director, sign the JRC site cleanup contract. (Photo: Amentum)
The European Commission Joint Research Centre (JRC) awarded a framework contract worth $112 million (about €97.6 million) to an Amentum-led joint venture to lead the cleanup of nuclear research sites in four European countries.
Europeans are taking resolute steps to reduce their output of climate-changing gases, but some countries are moving in the wrong direction.
Europeans are taking resolute steps to reduce their output of climate-changing gases, but some countries are moving in the wrong direction.
Many countries are adding solar and wind, which are low-carbon energy sources. Some have moved to biomass, the value of which as a climate cure is not clear. A few are adding reactors, while others are defining nuclear as dirty energy and natural gas as “clean” and are changing their generation mix accordingly.
A conceptual image of collaboration across Europe. (Image: PRISMAP/SCIPROM)
Only a few of the more than 3,000 radioisotopes that scientists have synthesized in the laboratory are regularly used in diagnostic or therapeutic medicine. One significant barrier to the development of new medical radioisotopes is the difficulty of gaining access to radionuclides during the early stages of development and research. PRISMAP is a new medical radionuclide program designed to streamline that access for medical research in the European Union and the United Kingdom.